IRIS
LEPEDDA, Antonio Junior
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.525
AS - Asia 2.790
EU - Europa 1.587
SA - Sud America 1.545
AF - Africa 99
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 9
Totale 10.571
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.418
BR - Brasile 1.380
SG - Singapore 1.100
CN - Cina 836
UA - Ucraina 528
IT - Italia 283
HK - Hong Kong 268
VN - Vietnam 223
DE - Germania 212
FR - Francia 185
FI - Finlandia 92
GB - Regno Unito 82
SE - Svezia 65
AR - Argentina 64
TR - Turchia 57
IQ - Iraq 48
CA - Canada 44
IN - India 42
MX - Messico 36
BD - Bangladesh 35
ZA - Sudafrica 34
EC - Ecuador 32
PK - Pakistan 26
RU - Federazione Russa 26
UZ - Uzbekistan 23
MA - Marocco 21
KR - Corea 18
PL - Polonia 17
BE - Belgio 16
CO - Colombia 15
JP - Giappone 15
NL - Olanda 15
EU - Europa 13
ID - Indonesia 13
KE - Kenya 12
VE - Venezuela 12
NP - Nepal 10
PE - Perù 10
PY - Paraguay 10
CL - Cile 9
DZ - Algeria 9
ES - Italia 9
GR - Grecia 9
AU - Australia 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DK - Danimarca 7
PH - Filippine 7
CZ - Repubblica Ceca 6
KZ - Kazakistan 6
TN - Tunisia 6
UY - Uruguay 6
AT - Austria 5
CR - Costa Rica 5
IL - Israele 5
JO - Giordania 5
MY - Malesia 5
AL - Albania 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
IR - Iran 4
JM - Giamaica 4
KG - Kirghizistan 4
LT - Lituania 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
EG - Egitto 3
GT - Guatemala 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CG - Congo 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
PA - Panama 2
RO - Romania 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BH - Bahrain 1
BW - Botswana 1
CH - Svizzera 1
CY - Cipro 1
GD - Grenada 1
HU - Ungheria 1
IE - Irlanda 1
Totale 10.556
Salva come PNG Salva come JPEG
Città #
Dallas 1.465
Singapore 609
Chandler 559
Jacksonville 322
Hong Kong 267
Ashburn 230
San Jose 217
Princeton 174
Beijing 172
New York 149
Nanjing 133
Sassari 123
São Paulo 110
Lauterbourg 86
Ann Arbor 82
Wilmington 79
Ho Chi Minh City 76
Dearborn 69
Nanchang 59
Shanghai 57
Los Angeles 50
Rio de Janeiro 48
Hanoi 47
Boardman 44
Santa Clara 43
Belo Horizonte 37
Tianjin 34
Changsha 32
Shenyang 32
Baghdad 29
Hebei 29
Woodbridge 28
Curitiba 26
Izmir 26
Campinas 23
Orem 23
Jiaxing 21
Johannesburg 21
Tashkent 21
Porto Alegre 20
Brasília 18
Buffalo 18
Council Bluffs 18
Seoul 18
Denver 17
Toronto 17
Warsaw 17
Brussels 16
Kunming 16
San Francisco 16
Zhengzhou 16
Hangzhou 15
Da Nang 14
London 14
Montreal 14
Mountain View 14
Salvador 14
Tokyo 14
Andover 13
Goiânia 13
Guarulhos 13
Haiphong 13
Ningbo 13
Ribeirão Preto 13
Stockholm 13
Villiers-sur-marne 13
Guayaquil 12
Norwalk 12
Atlanta 11
Fortaleza 11
Frankfurt am Main 11
Jinan 11
Manaus 11
Manchester 11
Nairobi 11
Brooklyn 10
Chennai 10
Dhaka 10
Guangzhou 10
Houston 10
Phoenix 10
Quito 10
Recife 10
Sorocaba 10
Amsterdam 9
Ankara 9
Bauru 9
Blumenau 9
Boston 9
Helsinki 9
Mexico City 9
Munich 9
Santo André 9
Taubaté 9
Campo Grande 8
Casablanca 8
Columbus 8
Juiz de Fora 8
Osasco 8
Poplar 8
Totale 6.391
Salva come PNG Salva come JPEG
Nome #
A novel LIF-CE method for the separation of hyaluronan- and chondroitin sulfate-derived disaccharides: Application to structural and quantitative analyses of human plasma low- and high-charged chondroitin sulfate isomers 218
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 191
A poly-L-lactic acid/ collagen/glycosaminoglycan matrix for tissue engineering applications 184
Natural collagenic skeleton of marine sponges in pharmaceutics: Innovative biomaterial for topical drug delivery 180
Apolipoprotein Profiles in Atherosclerotic Disease 177
Apolipoprotein profiles in atherosclerotic disease 170
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 159
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 158
Applications of two-dimensional electrophoresis technology to the study of atherosclerosis 158
Molecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report 157
Content and distribution of glycosaminoglycans/proteoglycans in human thoracic aortic aneurysm 154
Apolipoprotein Profiles in Atherosclerotic Disease 153
Analysis of changes in tyrosine and serine phosphorylation of red cell membrane proteins induced by P. falciparum growth 150
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 148
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 147
Short-end injection capillary electrophoresis for quantification of plasma chondroitin sulfate isomer disaccharides 147
Differential proteomic analysis of human atherosclerotic plaque extracts 143
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 143
Apolipoprotein profiles in atherosclerotic disease 142
Gradients in pore size enhance the osteogenic differentiation of human mesenchymal stromal cells in three-dimensional scaffolds 141
A Method for Urinary Trypsin Inhibitor (UTI) Purification Combining Anion-Exchange Chromatography Enrichment and Preparative SDS-PAGE 135
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 135
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 134
A Collagen-GAG synthetic extracellular matrix entrapped into PLLA polymeric scaffolds. 134
A proteomic approach to identify circulating or tissue biomarkers of atherosclerosis 132
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 132
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 131
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 130
Glycosaminoglycan functionalization of electrospun scaffolds enhances Schwann cell activity 130
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 130
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. IF 2010: 4.824 JCR: Q1 127
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 126
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 125
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 125
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 121
Apolipoprotein signature of hdl and ldl from atherosclerotic patients in relation with carotid plaque typology: A preliminary report 119
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 118
Identification and characterization of biomarkers in atherosclerosis and diabetes. 115
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 114
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 114
Tuning Cell Differentiation into a 3D Scaffold Presenting a Pore Shape Gradient for Osteochondral Regeneration 111
Marine-derived sulfated polysaccharides enhance hemocompatibility and endothelialization of nanofibrous PCL for vascular graft applications 109
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 108
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 105
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 105
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 103
Protein sulfhydryl-group oxidation in stable and unstable human carotid plaques 102
Urine bikunin as a marker of renal impairment in Fabry's disease 101
Influencing chondrogenic differentiation of human mesenchymal stromal cells in scaffolds displaying a structural gradient in pore size 100
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease 100
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 100
GAG content and distribution in porcine aortic valve tissue and in acellular pericardium scaffolds from three mammal species 98
Protein oxidation in unstable plaque extracts from human carotid segments 97
Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics 96
Role of the small proteoglycan bikunin in human reproduction 96
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 94
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 94
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 93
Oxidative Modifications in Advanced Atherosclerotic Plaques: A Focus on In Situ Protein Sulfhydryl Group Oxidation 92
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 92
Glycosaminoglycan content and distribution in human normal and varicose veins 91
New Capillary Zone Electrophoresis (CZE) method for glycosaminoglycan analysis 91
Protein sulfhydryl-groups oxidation in stable and unstable human carotid plaques 91
Glycosaminoglycans: From Vascular Physiology to Tissue Engineering Applications 89
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 88
Overview of Current Proteomic Approaches for Discovery of Vascular Biomarkers of Atherosclerosis 88
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 88
Structural analysis of glycosaminoglycans and proteoglycans from fresh porcine aortic valves 87
Sequence variability of apolipoprotein E gene in Corsico-Sardinian ovines 86
GLYCOSAMINOGLYCAN DIVERSITY IN MARINE SPONGE EXTRACELLULAR MATRIX 83
Morphological and biochemical traits of target marine sponges 83
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 83
Effects of Acidic Polysaccharide-Enriched Extracts from Holothuria tubulosa on Two- and Three-Dimensional Invasive Breast Cancer Cell Models 82
Glycosaminoglycan diversity in marine sponge extracellular matrix 82
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 82
Circulating Proteoglycans/Glycosaminoglycans as Cancer Biomarkers 81
Evidence for a pro-oxidant environment in atherosclerotic plaques from human carotid segments 80
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 79
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 78
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 77
Glycosaminoglycans and fabry’s disease 77
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 77
Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus 73
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 73
Ultrasensitive Capillary Zone Electrophoresis (CZE) for glycosaminoglycan analisys in normal human plasma 73
Human serum albumin Cys34 oxidative modifications after infiltration in the carotid atherosclerotic plaque 72
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 72
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 69
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 69
Proteomic analysis of differential protein expression and post-translational modifications in human atherosclerotic plaques 68
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 68
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 68
Structural analysis of plasma glycosaminoglycans in patients undergoing carotid endarterectomy 68
Human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 68
Molecular and pathobiological insights of bikunin/UTI in cancer 67
Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability 61
Urine bikunin and kidney involvement in Fabry disease 48
Evolutionary History of the Adult β- Globin Gene in Wild Sheep: First Sequences From the Argali (Ovis ammon) and the Urial (Ovis vignei) 16
Tunable Bioresorbable Scaffolds With Marine Sulfated Polysaccharides for Small-Caliber Vascular Grafts: A Multi-Layered Strategy Combining Electrospinning and 4-Axis Printing 14
Emerging Insights into the Pathobiology of Acute Coronary Syndromes 8
Totale 10.641
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.933
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 93 16 10
2021/2022477 53 3 3 11 10 2 25 31 63 34 56 186
2022/2023996 94 82 10 185 112 157 0 122 163 13 40 18
2023/2024359 49 25 7 12 83 76 14 8 9 11 36 29
2024/20252.733 19 23 155 43 114 67 205 464 969 454 155 65
2025/20264.041 178 916 768 605 461 240 440 132 172 129 0 0
Totale 10.646